middle.news

Acrux Surpasses Prior Year Profit Share in September Quarter

12:11pm on Friday 31st of October, 2025 AEDT Pharmaceuticals
Read Story

Acrux Surpasses Prior Year Profit Share in September Quarter

12:11pm on Friday 31st of October, 2025 AEDT
Key Points
  • September quarter profit share income exceeds entire previous financial year
  • Revenue growth led by Nitroglycerin 0.4% Ointment and Dapsone gels
  • Received $3.04 million R&D Tax Incentive rebate from Australian Tax Office
  • Full repayment of short-term R&D advances from Radium Capital
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Acrux (ASX:ACR)
OPEN ARTICLE